← Browse by Condition
Medical Condition

namd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05562947 Phase 3
Recruiting

A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

Enrollment
68 pts
Location
China
Sponsor
Hoffmann-La Roche
View Trial →